...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Is this bad for RVX but right, on the money?

"CALGARY, Alberta, March 23, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”) (TSX: RVX) announces that it is seeking to collaborate with organizations currently testing therapies for SARS-CoV-2 (the virus responsible for COVID-19) in pre-clinical or clinical models." ( bolding added)

Who are these organizations that RVX is seeking collaboration with?

 

Koo

Share
New Message
Please login to post a reply